申请人:Pfizer Inc
公开号:US20040152691A1
公开(公告)日:2004-08-05
The invention relates to compounds of the formula 1
1
or pharmaceutically acceptable salts, prodrugs, solvates or hydrates thereof, wherein wherein X, R
1
, and R
2
are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula 1 and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula 1.
本发明涉及公式11化合物或其药学上可接受的盐、前药、溶剂或水合物,其中X、R1和R2的定义如本文所述。本发明还涉及包含公式1化合物的制药组合物以及通过给予公式1化合物治疗哺乳动物的增殖过度性疾病的方法。